Capital World Investors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $616M | Buy |
21,947,486
+513,596
| +2% | +$13.7M | 0.08% | 184 |
|
|
2025
Q4 | $534M | Buy |
21,433,890
+7,287,194
| +52% | +$184M | 0.07% | 196 |
|
|
2025
Q3 | $360M | Buy |
14,146,696
+286,493
| +2% | +$7.07M | 0.05% | 226 |
|
|
2025
Q2 | $336M | Sell |
13,860,203
-13,368,274
| -49% | -$312M | 0.05% | 230 |
|
|
2025
Q1 | $690M | Sell |
27,228,477
-16,386,931
| -38% | -$429M | 0.11% | 161 |
|
|
2024
Q4 | $1.16B | Sell |
43,615,408
-10,072,797
| -19% | -$273M | 0.18% | 119 |
|
|
2024
Q3 | $1.55B | Sell |
53,688,205
-34,454,459
| -39% | -$1.01B | 0.24% | 107 |
|
|
2024
Q2 | $2.47B | Sell |
88,142,664
-24,518,817
| -22% | -$675M | 0.4% | 67 |
|
|
2024
Q1 | $3.13B | Sell |
112,661,481
-60,732,791
| -35% | -$1.69B | 0.52% | 46 |
|
|
2023
Q4 | $4.99B | Sell |
173,394,272
-8,798,010
| -5% | -$266M | 0.89% | 20 |
|
|
2023
Q3 | $6.04B | Sell |
182,192,282
-16,820,524
| -8% | -$595M | 1.2% | 15 |
|
|
2023
Q2 | $7.3B | Sell |
199,012,806
-32,499,562
| -14% | -$1.26B | 1.4% | 10 |
|
|
2023
Q1 | $9.45B | Sell |
231,512,368
-24,584,436
| -10% | -$1.06B | 1.95% | 7 |
|
|
2022
Q4 | $13.1B | Buy |
256,096,804
+7,246,275
| +3% | +$347M | 2.8% | 4 |
|
|
2022
Q3 | $10.9B | Sell |
248,850,529
-1,276,218
| -0.5% | -$62M | 2.44% | 6 |
|
|
2022
Q2 | $13.1B | Buy |
250,126,747
+30,250,912
| +14% | +$1.54B | 2.79% | 5 |
|
|
2022
Q1 | $11.4B | Sell |
219,875,835
-16,982,581
| -7% | -$881M | 1.96% | 6 |
|
|
2021
Q4 | $14B | Sell |
236,858,416
-4,502,442
| -2% | -$223M | 2.21% | 7 |
|
|
2021
Q3 | $10.4B | Buy |
241,360,858
+1,171,443
| +0.5% | +$51.9M | 1.77% | 8 |
|
|
2021
Q2 | $9.41B | Buy |
240,189,415
+10,103,021
| +4% | +$393M | 1.6% | 9 |
|
|
2021
Q1 | $8.34B | Sell |
230,086,394
-36,561,224
| -14% | -$1.3B | 1.54% | 9 |
|
|
2020
Q4 | $9.82B | Sell |
266,647,618
-6,534,739
| -2% | -$240M | 1.89% | 8 |
|
|
2020
Q3 | $9.51B | Buy |
273,182,357
+15,544,169
| +6% | +$545M | 2.08% | 7 |
|
|
2020
Q2 | $7.99B | Buy |
257,638,188
+20,690,437
| +9% | +$703M | 1.93% | 8 |
|
|
2020
Q1 | $7.34B | Buy |
236,947,751
+38,041,730
| +19% | +$1.3B | 2.13% | 6 |
|
|
2019
Q4 | $7.39B | Buy |
198,906,021
+23,432,587
| +13% | +$835M | 1.65% | 9 |
|
|
2019
Q3 | $5.98B | Buy |
175,473,434
+4,734,822
| +3% | +$172M | 1.44% | 13 |
|
|
2019
Q2 | $7.02B | Buy |
170,738,612
+14,393,917
| +9% | +$572M | 1.65% | 10 |
|
|
2019
Q1 | $6.3B | Buy |
156,344,695
+24,149,232
| +18% | +$967M | 1.53% | 12 |
|
|
2018
Q4 | $5.47B | Buy |
132,195,463
+42,570,723
| +47% | +$1.77B | 1.48% | 13 |
|
|
2018
Q3 | $3.75B | Buy |
89,624,740
+49,751,368
| +125% | +$1.92B | 0.91% | 27 |
|
|
2018
Q2 | $1.37B | Buy |
39,873,372
+22,023,882
| +123% | +$753M | 0.29% | 90 |
|
|
2018
Q1 | $601M | Hold |
17,849,490
| – | – | 0.14% | 155 |
|
|
2017
Q4 | $613M | Hold |
17,849,490
| – | – | 0.13% | 151 |
|
|
2017
Q3 | $605M | Sell |
17,849,490
-6,896,322
| -28% | -$222M | 0.14% | 141 |
|
|
2017
Q2 | $789M | Sell |
24,745,812
-976,275
| -4% | -$30.8M | 0.19% | 116 |
|
|
2017
Q1 | $835M | Sell |
25,722,087
-5,215,199
| -17% | -$164M | 0.2% | 108 |
|
|
2016
Q4 | $953M | Sell |
30,937,286
-53,317,886
| -63% | -$1.63B | 0.24% | 104 |
|
|
2016
Q3 | $2.71B | Buy |
84,255,172
+14
| +0% | +$468 | 0.7% | 39 |
|
|
2016
Q2 | $2.81B | Sell |
84,255,158
-5,581,900
| -6% | -$178M | 0.76% | 37 |
|
|
2016
Q1 | $2.53B | Sell |
89,837,058
-4,043,881
| -4% | -$116M | 0.7% | 39 |
|
|
2015
Q4 | $2.88B | Sell |
93,880,939
-46,610,832
| -33% | -$1.47B | 0.8% | 30 |
|
|
2015
Q3 | $4.19B | Sell |
140,491,771
-319,467
| -0.2% | -$10.2M | 1.23% | 14 |
|
|
2015
Q2 | $4.48B | Sell |
140,811,238
-1,480,870
| -1% | -$48.3M | 1.21% | 15 |
|
|
2015
Q1 | $4.7B | Buy |
142,292,108
+10,004,146
| +8% | +$318M | 1.27% | 13 |
|
|
2014
Q4 | $3.91B | Sell |
132,287,962
-4,377,262
| -3% | -$126M | 1.06% | 20 |
|
|
2014
Q3 | $3.83B | Buy |
136,665,224
+6,177,494
| +5% | +$173M | 1.08% | 19 |
|
|
2014
Q2 | $3.67B | Buy |
130,487,730
+2,108,000
| +2% | +$60.1M | 1.01% | 23 |
|
|
2014
Q1 | $3.91B | Buy |
128,379,730
+5,098,852
| +4% | +$152M | 1.12% | 18 |
|
|
2013
Q4 | $3.58B | Sell |
123,280,878
-2,174,402
| -2% | -$63.3M | 1.01% | 22 |
|
|
2013
Q3 | $3.42B | Buy |
125,455,280
+10,787,690
| +9% | +$294M | 1.04% | 20 |
|
|
2013
Q2 | $3.05B | Buy |
+114,667,590
| New | +$3.17B | 0.99% | 23 |
|
Other funds holding PFE
VCM
VPM
Capital World Investors's PFE Position: Q1 2026 in Review
Capital World Investors increased its Pfizer (PFE) stake by 2.4% in Q1 2026, buying an estimated $13.7M and bringing the position to 21,947,486 shares worth $616M. The position accounts for 0.08% of the portfolio, ranked #184.
Capital World Investors first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $14B in Q4 2021. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Capital World Investors held 21,947,486 shares of Pfizer worth $616M as of Q1 2026.
- Capital World Investors bought 513,596 Pfizer shares in Q1 2026, an estimated $13.7M.
- Pfizer made up 0.08% of Capital World Investors's portfolio in Q1 2026, its #184 holding.
- Capital World Investors first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Capital World Investors's Pfizer position peaked at $14B in Q4 2021.
- 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Capital World Investors's 13F filing for Q1 2026, filed 13 May 2026.